Minneapolis, MINNESOTA1 Active Studies

Traumatic Brain Injury Clinical Trials in Minneapolis, MINNESOTA

Find 1 actively recruiting traumatic brain injury clinical trials in Minneapolis, MINNESOTA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
200
Enrolling

Recruiting Traumatic Brain Injury Studies in Minneapolis

About Traumatic Brain Injury Clinical Trials in Minneapolis

Traumatic brain injury (TBI) results from a violent blow or jolt to the head or body that disrupts normal brain function. Effects can range from mild concussions to severe cognitive impairment. Treatment depends on severity and may include rehabilitation, medication, and surgery.

There are currently 1 traumatic brain injury clinical trials recruiting participants in Minneapolis, MINNESOTA. These studies are seeking a combined 200 participants. Research is being sponsored by Hennepin Healthcare Research Institute. Clinical trial participation is free and participants receive study-related medical care at no cost.

Traumatic Brain Injury Clinical Trials in Minneapolis — FAQ

Are there traumatic brain injury clinical trials in Minneapolis?

Yes, there are 1 traumatic brain injury clinical trials currently recruiting in Minneapolis, MINNESOTA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Minneapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.

Are clinical trials in Minneapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.

What traumatic brain injury treatments are being tested?

The 1 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for traumatic brain injury.

Data updated March 2, 2026 from ClinicalTrials.gov